MAPT and Cognitive impairment: We chose to use PS1-KI animals as control group as these mice overexpress mutant Presenilin-1 gene (M146V substitution) but, by lacking the expression of mutant APP and h-tau, do not show Aβ or tau-dependent pathology nor AD-related cognitive deficits [30].